Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
University of Texas Southwestern Medical Center Home
Home
Profiles
Research Units
Equipment
Research output
Search by expertise, name or affiliation
Combined-modality therapy for advanced non-small cell lung cancer: Paclitaxel and thoracic irradiation
H. Choy
, L. Yee, B. F. Cole
Radiation Oncology
Radiation Oncology - Administration
Research output
:
Contribution to journal
›
Article
›
peer-review
18
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Combined-modality therapy for advanced non-small cell lung cancer: Paclitaxel and thoracic irradiation'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Combined Modality Therapy
100%
Paclitaxel
81%
Non-Small Cell Lung Carcinoma
71%
Thorax
55%
Radiation
36%
Esophagitis
18%
Maximum Tolerated Dose
18%
Hypersensitivity
13%
Appointments and Schedules
13%
Outpatients
12%
Radiation Pneumonitis
11%
Premedication
9%
Neutropenia
8%
Radiotherapy
5%